Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice.
Antonio NicolucciRiccardo CandidoDomenico CucinottaGiusi GrazianoAlberto RoccaMaria C RossiFranco TuccinardiValeria ManicardiPublished in: Advances in therapy (2019)
AstraZeneca.
Keyphrases